| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.63M | -10,000 | |
| VP | 83.7K | $16.19M | - | |
| VP | 38.3K | $7.42M | - | |
| VP | 34.5K | $6.67M | - | |
| CFO | 33.4K | $6.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2016 | Britell Jenne K | Director | Sale+OE | 4,000 | $85.20 | $340,808.00 | -16.7% | |
| Aug 3, 2016 | Leiden Jeffrey M47 | Director | Sale+OE | 6,345 | $85.62 | $543,262.48 | -14.7% | |
| Jul 25, 2016 | Ziegler John B | Director | Sell | 1,000 | $84.36 | $84,359.00 | -5.1% | |
| May 27, 2016 | Doherty Catherine T.55 | SVP, Clin. Franchise Solutions | Sale+OE | 47,334 | $77.27 | $3,657,308.84 | -21.1% | |
| May 12, 2016 | Britell Jenne K | Director | Sale+OE | 8,000 | $75.68 | $605,456.00 | -40.7% | |
| May 9, 2016 | Cunningham Everett54 | SVP, Commercial | Sale+OE | 56,312 | $76.26 | $4,294,396.04 | -46.9% | |
| May 6, 2016 | Cunningham Everett54 | SVP, Commercial | Sale+OE | 50,447 | $76.00 | $3,833,972.00 | -34.6% | |
| Apr 25, 2016 | Doherty Catherine T.55 | SVP, Clin. Franchise Solutions | Sale+OE | 29,550 | $74.45 | $2,199,916.35 | -15.6% | |
| Mar 1, 2016 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 3,815 | $68.22 | $260,264.56 | -4.3% | |
| Aug 12, 2015 | Baldwin John C Md | Director | Sell | 2,266 | $72.00 | $163,152.00 | -14.9% |